strontium ranelate: Clinical Trials

6 trials of strontium ranelate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 5 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Unknown 1
Not applicable1Completed 1

Follow strontium ranelate: new trials by email Literature Review of strontium ranelate trials Research Report on strontium ranelate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
Strontium Ranelate, Lacto-N-Hexaose - Fragility Fracture, Femur; Fracture, Pertrochanteric
Phase 4UnknownAga Khan University Hospital, Pakistan1002021-11-012023-02-03
Strontium Ranelate and KOA
Strontium Ranelate, physiotherapy - Knee Osteoarthritis
Not applicableCompletedMansoura University302018-07-012020-05-05
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Strontium Ranelate + Ca/Vitamin-D, Placebo - Primary Hyperparathyroidism, Osteopenia
Phase 4CompletedMedical University of Vienna632010-09-012015-01-21
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Raloxifene, Strontium ranelate - Postmenopausal Osteoporosis, Compliance
Phase 4CompletedUniversity of Valencia802009-09-012012-09-03
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Full Length Parathyroid Hormone, PTH(1-84), Strontium Ranelate - Osteoporosis
Phase 4CompletedNycomed822007-04-012012-05-08
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
Teriparatide, Strontium ranelate, Transiliac bone biopsy - Postmenopausal Osteoporosis
Phase 4CompletedEli Lilly and Company732005-09-012007-06-12

Conditions studied

Osteoporosis (2)  ·  Osteoporosis, Postmenopausal (2)  ·  Bone Diseases, Metabolic (1)  ·  Fractures, Bone (1)  ·  Hyperparathyroidism, Primary (1)  ·  Osteoarthritis, Knee (1)  ·  Patient Compliance (1)

Sponsors

Aga Khan University Hospital, Pakistan (1)  ·  Eli Lilly and Company (1)  ·  Mansoura University (1)  ·  Medical University of Vienna (1)  ·  Nycomed (1)  ·  University of Valencia (1)

Countries

Spain (2)  ·  Austria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)  ·  Mexico (1)  ·  Pakistan (1)

Top investigators

Antonio Cano, MD (1)  ·  Bruno Niederle, Prof., MD (1)

NIH funding

2008 (1)